The Asia Pacific fertility market size accounted for USD 7.86 billion in 2025 and is predicted to touch around USD 19.48 billion by 2035, growing at a CAGR of 9.5% from 2026 to 2035. This growth is due to the rising age of first pregnancy and improved access to IVF.

Asia Pacific Fertility Market Statical Scope

The Asia-Pacific fertility market has transformed into one of the most dynamic regions worldwide, demonstrating high demand and rapid adoption of advanced technologies. Factors such as increased awareness of various infertility treatments, a decline in fertility rates, advancements in ART, and the proliferation of fertility clinics in the region are anticipated to propel the growth of the Asia-Pacific fertility services market during the forthcoming period. Governmental financial assistance and subsidies in this region have made these treatments more accessible for couples. A heightened awareness of reproductive health issues and a diminishing stigma surrounding infertility have prompted more individuals to seek assistance.

Asia Pacific Fertility Market Share, By Country, 2025, (%)

• India- The India fertility market is experiencing a dynamic evolution driven by delayed parenthood and rising infertility, drawing investors into the fertility market.

Asia Pacific Fertility Market Share, By Offering, 2025, (%)

• Assisted Reproductive Technology- Technology-driven solutions like IVF and ICSI for fertility treatment dominate with 70% share due to high demand for advanced, reliable fertility treatments and significant clinical success.
• Fertility drugs- Pharmaceutical solutions to support ovulation and hormone regulation in fertility treatments, holds 30% share, due to their high efficacy and widespread use in IVF cycles.

Asia Pacific Fertility Market Share, By End User, 2025, (%)

• Fertility clinics- Specialized healthcare centers focused on infertility diagnosis and treatment. Dominating with 55% share due to the growing number of fertility-focused centers offering personalized care and treatment options.
• Hospitals- General healthcare institutions providing fertility treatments as part of a broader service holds 30% share due to patient preference for integrated, one-stop, and secure care.
• Clinical research institutes- Research-focused entities studying fertility treatments and reproductive health, and hold 15% share, as their role is primarily in research and clinical trials rather than direct patient care.

Top Companies in the Asia Pacific Fertility Market

• Fertility Market Companies
• Boston IVF Fertility Clinic
• INVO Bioscience
• San Diego Fertility Center
• Celmatix
• FUJIFILM IRVINE SCIENTIFIC
• Carolinas Fertility Institute
• Progyny Inc.
• Cook Medical

Segments Covered in the Report

By Offering

• Assisted Reproductive Technology
  
  • IVF
  • Artificial Insemination
  • Surrogacy
  • Others
• Fertility Drugs
  
  • Gonadotropin
  • Anti-estrogen
  • Others

By End user

• Fertility Clinics
• Hospitals
• Clinical Research Institutes